Một tác nhân neuroprotection liên quan đến bệnh Alzheimer cứu sống các tế bào hạch võng mạc chuột chuyển hóa khỏi sự apoptosis do CoCl2 gây ra

Arakawa T, Kita Y, Niikura T (2008) A rescue factor for Alzheimer’s diseases: discovery, activity, structure, and mechanism. Curr Med Chem 15:2086–2098 Arjamaa O, Nikinmaa M (2006) Oxygen-dependent diseases in the retina: role of hypoxia-inducible factors. Exp Eye Res 83:473–483 Benakia D, Zikosb C, Evangeloub A, Livanioub E, Vlassia M, Mikrosc E, Pelecanou M (2005) Solution structure of humanin, a peptide against Alzheimer’s disease-related neurotoxicity. Biochem Biophys Res Commun 329:152–160 Goldblum D, Kipfer-Kauer A, Sarra GM, Wolf S, Frueh BE (2007) Distribution of amyloid precursor protein and amyloid-beta immunoreactivity in DBA/2J glaucomatous mouse retinas. Invest Ophthalmol Vis Sci 48:5085–5090 Guo B, Zhai D, Cabezas E, Welsh K, Nouraini S, Satterthwait AC, Reed JC (2003) Humanin peptide suppresses apoptosis by interfering with Bax activation. Nature 423:456–466 Guo L, Salt TE, Luong V, Wood N, Cheung W, Maass A, Ferrari G, Russo-Marie F, Sillito AM, Cheetham ME, Moss SE, Fitzke FW, Cordeiro MF (2007) Targeting amyloid-beta in glaucoma treatment. Proc Natl Acad Sci 104:13444–13449 Hashimoto Y, Kurita M, Aiso S, Nishimoto I, Matsuoka M (2009) Humanin inhibits neuronal cell death by interacting with a cytokine receptor complex or complexes involving CNTF receptor alpha/WSX-1/gp130. Mol Biol Cell 20:2864–2873 Hashimoto Y, Niikura T, Tajima H, Yasukawa T, Sudo H, Ito Y, Kita Y, Kawasumi M, Kouyama K, Doyu M, Sobue G, Koide T, Tsuji S, Lang J, Kurokawa K, Nishimoto I (2001) A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer’s disease genes and Aβ. Proc Natl Acad Sci U S A 98:6336–6341 Hashimoto Y, Suzuki H, Aiso S, Niikura T, Nishimoto I, Matsuoka M (2005) Involvement of tyrosine kinases and STAT3 in humanin-mediated neuroprotection. Life Sci 17:3092–3104 Jung SS, Van Nostrand WE (2003) Humanin rescues human cerebrovascular smooth muscle cells from Aβ-induced toxicity. J of Neurochem 84:266–272 Kariya S, Takahashi N, Hirano M, Ueno S (2003) Humanin improves impaired metabolic activity and prolongs survival of serum-deprived human lymphocytes. Mol Cell Biochem 254:83–89 Kariya S, Takahashi N, Ooba N, Kawahara M, Nakayama H, Ueno S (2002) Humanin inhibits cell death of serum-deprived PC12 cells. Neuroreport 13:903–907 Kariya S, Hirano M, Furiya Y, Ueno S (2005) Effect of humanin on decreased ATP levels of human lymphocytes harboring A3243G mutant mitochondrial DNA. Neuropeptides 39:97–101 Krejcova G, Patocka J, Slaninova J (2004) Effect of humanin analogues on experimentally induced impairment of spatial memory in rats. J J Pept Sci 10:636–639 Krishnamoorthy RR, Agarwal P, Prasanna G, Vopat K, Lambert W, Sheedlo HJ, Pang IH, Shade D, Wordinger RJ, Yorio T, Clark AF, Agarwal N (2001) Characterization of a transformed rat retinal ganglion cell line. Mol Brain Res 86:1–12 Li J, Dong ZZ, Liu BQ, Zhuo YH, Sun XR, Yang ZK, Ge J, Tan ZQ (2011) Hypoxia induces beta-amyloid in association with death of RGC-5 cells in culture. Biochem Biophys Res Commun 410:40–44 Mamiya T, Ukai M (2001) [gly(14)]-Humanin improved the learning and memory impairment induced by scopolamine in vivo. Br J Pharmacol 134:1597–1599 McKinnon SJ (2003) Glaucoma: ocular Alzheimer’s disease? Front Biosci 1:1140–1156 McKinnon SJ, Lehman DM, Kerrigan-Baumrind LA, Merges CA, Pease ME, Kerrigan DF, Ransom NL, Tahzib NG, Reitsamer HA, Levkovitch-Verbin H, Quigley HA, Zack DJ (2002) Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. Invest Ophthalmol Vis Sci 43:1077–1087 Osborne NN, Casson RJ, Wood JPM, Chidlow G, Graham M, Melena J (2004) Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res 23:91–147 Sponne I, Fifre A, Koziel V, Kriem B, Oster T, Pillot T (2004) Humanin rescues cortical neurons from prion-peptide-induced apoptosis. Mol Cell Neurosci 25:95–102 Tajima H, Niikura T, Hashimoto Y, Ito Y, Kita Y, Terashita K, Yamazaki K, Koto A, Aiso S (2002) Alzheimer’s disease-related insults. Neurosci Lett 324:227–231 Tamura H, Kawakami H, Kanamoto T, Tamura H, Kato T, Yokoyama T, Sasaki K, Izumi Y, Matsumoto M, Mishima HK (2006) High frequency of open-angle glaucoma in Japanese patients with Alzheimer’s disease. J Neurol Sci 246:79–83 Tezel G, Wax MB (2004) Hypoxia-inducible factor 1 alpha in the glaucomatous retinal and optic nerve head. Arch Ophthalmol 122:1348–1356 Wostyn P, Audenaert K, De DPP (2009) Alzheimer’s disease and glaucoma: is there a causal relationship? Br J Ophthalmol 93:1557–1559 Ying G, Iribarren P, Zhou Y, Gong W, Zhang N, Yu ZX, Le Y, Cui Y, Wang JM (2004) Humanin, a newly identified neuroprotective factor, uses the G protein-coupled formylpeptide receptor-like-1 as a functional receptor. J Immunol 172:7078–7085 Yoneda S, Hara H, Hirata A, Fukushima M, Inomata Y, Tanihara H (2005) Vitreous fluid levels of beta-amyloid(1–42) and tau in patients with retinal diseases. Jpn J Ophthalmol 49:106–108 Zhai D, Luciano F, Zhu X, Guo B, Satterthwait AC, Reed JC (2005) Humanin binds and nullifies Bid activity by blocking its activation of Bax and Bak. J Biol Chem 280:15815–15824 Zhu X, Zhou W, Cui Y, Zhu L, Li J, Xia Z, Shao B, Wang H, Chen H (2009) Muscarinic activation attenuates abnormal processing of beta-amyloid precursor protein induced by cobalt chloride-mimetic hypoxia in retinal ganglion cells. Biochem Biophys Res Commun 384:110–113